Kestra Private Wealth Services, LLC Ocuphire Pharma, Inc. Transaction History
Kestra Private Wealth Services, LLC
- $5.3 Billion
- Q3 2024
A detailed history of Kestra Private Wealth Services, LLC transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Kestra Private Wealth Services, LLC holds 42,341 shares of OCUP stock, worth $41,494. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,341
Previous 42,341
-0.0%
Holding current value
$41,494
Previous $64,000
14.06%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding OCUP
# of Institutions
43Shares Held
2.58MCall Options Held
14.1KPut Options Held
800-
Vanguard Group Inc Valley Forge, PA992KShares$972,3560.0% of portfolio
-
Geode Capital Management, LLC Boston, MA272KShares$266,8350.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX166KShares$162,4350.0% of portfolio
-
Richmond Brothers, Inc. Jackson, MI156KShares$152,5070.13% of portfolio
-
Black Rock Inc. New York, NY107KShares$104,7960.0% of portfolio
About Ocuphire Pharma, Inc.
- Ticker OCUP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,579,800
- Market Cap $20.2M
- Description
- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...